NCT03155997 2026-04-24monarchEEli Lilly and CompanyPhase 3 Active not recruiting5,637 enrolled 12 charts 2 FDA
NCT04975308 2025-07-11EMBER-3Eli Lilly and CompanyPhase 3 Active not recruiting874 enrolled 29 charts 1 FDA